Home | About PM | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |  Login 
Pharmacognosy Magazine
Search Article 
  
Advanced search 
 
ORIGINAL ARTICLE
Year : 2020  |  Volume : 16  |  Issue : 68  |  Page : 199-205

A bioinformatics-based investigation to screen and analyze the bioactivity of Piper longum Linn. compounds as a ground-breaking hostile to antidiabetic activity


1 Bioinformatics Centre, St. Edmund's College, Shillong 793003, Meghalaya, India
2 Department of Biotechnology, St. Edmund's College, Shillong 793003, Meghalaya, India

Correspondence Address:
Samrat Adhikari
Department of Biotechnology, St. Edmund's College, Shillong - 793 003, Meghalaya
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/pm.pm_400_19

Rights and Permissions

As of today, the utilization of herbal medicines has taken up the pace in treating diseases. This is due to the fact that they have lower risk of adverse reactions. Numerous plants are being used traditionally to treat various dreadful diseases including diabetes. Piper longum is one of the major and important medicinal plants in various systems of medicine, including the Ayurvedic system of medicine. Among the major bioactive compounds found in this plant, few compounds, viz., piperine, piperlongumine, piperlonguminine, and retrofractamide A, have been selected for studying the effectiveness on antidiabetic activity. An in silico approach was utilized to observe the major phytochemical properties and interaction studies of the constituents of P. longum, and finally, a pharmacophore investigation was carried out. In this study, we have observed the interaction of the four bioactive compounds taken from P. longum with the receptors via molecular docking technique. The binding of the ligands firmly with the receptors confirmed the fact that piperine, piperlongumine, piperlonguminine, and retrofractamide A act as inhibitors for dipeptidyl peptidase-4, GKRP, 11β-hydroxysteroid dehydrogenase type 1, glutamine-fructose-6-phosphate transaminase 1, and protein tyrosine phosphatase 1B, which encourage the glucose digestion and increment insulin affectability. The information acquired from this investigation might be taken further for in vitro examinations, which may, in the long run, be useful in recognizable proof of novel and successful particles. The outcomes acquired from this examination might provide strong understanding in the utility of phytochemicals against diabetes.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed231    
    Printed0    
    Emailed0    
    PDF Downloaded72    
    Comments [Add]    

Recommend this journal